Redeye: Better Collective - Increased focus on organic growth
Redeye updates on Better Collective following its Q4-results and guidance for 2025. While Q4-results were strong, the guidance indicated somewhat softer topline than we expected, however, the EBITDA-guidance was close to our forecast. The company also updated its 2023-27 outlook which no longer assumes any M&A on the back of increased focus on organic growth, while capital allocation will shift towards share buybacks and debt reduction.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/